http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2625222-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a39311cac7d83343c0891ece39d5a4d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2012-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c03dde84ab4c4a6ac50e3a5d80b74e45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d668f5528f9f4fa55f372a70e578717
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_231cfb4b3094c0b0f9aa8155e65a2a75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e8289aab497c8d848118a18211fce27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_595ce1223a7c3cafb8ca3bcc1949e2c6
publicationDate 2017-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2625222-C2
titleOfInvention Combined therapy with cd19 antibody and nitrogen mustard
abstract FIELD: biotechnology. n SUBSTANCE: CD19-specific antibody in synergistic combination with bendamustine for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia is declared. n EFFECT: invention provides for synergistic antitumor activity of specific CD19 antibodies and of bendamustine that can be used for effective treatment of B-cell malignancies. n 7 cl, 10 dwg, 10 tbl, 3 ex
priorityDate 2011-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007076950-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2228202-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008022152-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415956444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419500386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428545465
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4684
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564680
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8227
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73755215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865469
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454526095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6194
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID390986
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9502
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580760
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID393655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22094277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861628
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453947315
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123935

Total number of triples: 59.